Skip to main content

Recommendations to improve use and dissemination of patient versions of oncological clinical practice guidelines in Germany: results of a multi-stakeholder workshop

Abstract

Background

Oncological patients have high information needs that are often unmet. Patient versions of oncological clinical practice guidelines (PVG) translate clinical practice guidelines into laypersons’ language and might help to address patients’ information needs. Currently, 30 oncological PVG have been published in Germany and more are being developed. Following a large multi-phase project on oncological PVGs in Germany, recommendations to improve use and dissemination of PVG were adopted in a multi-stakeholder workshop.

Methods

Organisations representing users of PVGs (patients, medical personnel, and multipliers), creators, initiators/funding organisations of PVGs, and organisations with methodological expertise in the development of clinical practice guidelines or in patient health information were invited to participate. The workshop included a World Café for discussion of pre-selected recommendations and structured consensus procedure for of all recommendations. Recommendations with agreement of > 75% were approved, and in case of ≤ 75% agreement, recommendations were rejected.

Results

The workshop took place on 24th April 2023 in Cologne, Germany. Overall, 23 people from 24 organisations participated in the discussion. Of 35 suggested recommendations 28 recommendations reached consensus and were approved. The recommendations referred to the topics dissemination (N = 13), design and format (N = 7), (digital) links (N = 5), digitalisation (N = 4), up-to-dateness (N = 3), and use of the PVG in collaboration between healthcare providers and patients (N = 3).

Conclusion

The practical recommendations consider various perspectives and can help to improve use and dissemination of oncological PVG in Germany. The inclusion of different stakeholders could facilitate the transfer of the results into practice.

Peer Review reports

Background

Oncological patients have high information needs that are often unmet [1,2,3,4]. Unfulfilled information needs might be related to quality of life, level of depression and anxiety as well as physical symptoms [5, 6]. Patients’ needs range from the basic need for medical information and documentation, to the need for additional information and explanation to complement that provided by health professionals, to the need for support, assistance and advice depending on the difficulties encountered, to the need for listening and psychological support [7]. Patient versions of clinical practice guidelines (PVGs) as a special form of evidence-based practice information might help to address the basic need for medical information and documentation as well as need for additional information and explanation and they often provide contact addresses for additional support. PVGs translate clinical practice guidelines (CPG) into common speech [8]. CPG provide evidence-based recommendations with regard to medical conditions [9] and mainly aim to help health care providers in the decision-making process regarding appropriate care [9,10,11]. Patients can also use them as a source of information [12, 13]. The transformation into a PVGs helps to increase the understandability for laypersons, since the concept of CPGs is sometimes difficult for them to understand [14, 15]. However, PVGs do not only include a translation of the CPG, they often also contain further and explanatory information. Examples are the introduction to the grading of recommendations, but also background information on the disease comprehensible to patients or further addresses, for example to self-help groups.

In Germany, the German Guideline Program in Oncology (GGPO) develops oncological PVGs for various diseases. Currently, 30 oncological PVG have been published by the GGPO and more are being developed. These PVGs are available in PDF format and as a printed brochure. The printed brochures can be ordered at the website of the German Cancer Aid [16]. The PDF versions can also be downloaded from this website as well as from the website of the GGPO [17]. Both are available free of charge. The development process follows a strict methodology [18].

To our knowledge, there is only scarce information on the use and applicability of oncological PVGs in Germany. To obtain information on this as well as on possible ways for improvements, a large multi-phase study was carried out. The study included a review to assess international methods and approaches of PVGs [19], qualitative interviews on experiences of international guideline producers as well as qualitative interviews and focus groups to analyse the national perspective on the implementation and dissemination of PVGs. Further information on the study can be found in the protocol [20]. The last stage of the study was the development of recommendations based on the previous study results and on the knowledge of several stakeholders within a workshop.

The aim was to formulate recommendations that can improve the use and dissemination of PVGs based on the results of the main project and the consultation of several stakeholders. This will help to transfer the results into practice.

Methods

Design

To formulate recommendations for improvement, a one-day workshop was held consisting of a World Café and subsequent voting on the recommendations. The World Café is a method for engaging people in discussions on diverse topics [21]. Unfortunately, we are not aware of any reporting guidelines for publications following a workshop. Accordingly, we did not use any reporting guideline for the preparation of the manuscript.

Recruitment

Invitations were sent by e-mail to 50 organisations from German-speaking countries. Users of PVGs (patients, medical staff, and multipliers) were included as well as creators and initiators/funding organisations of PVGs and organisations with methodological expertise in the development of clinical practice guidelines or in patient health information. The organisations were selected in cooperation with the project partners: the GGPO, the Association of the Scientific Medical Societies in Germany - Institute for Medical Knowledge Management (AWMF-IMWi), the German Agency for Quality in Medicine (ÄZQ), and two German self-help groups focusing on prostate cancer (Bundesverband Prostatakrebs Selbsthilfe [BPS]) and cancer in women (Frauenselbsthilfe Krebs–Bundesverband [FSH]). A save the date was sent in June 2022, followed by the initial invitation in October 2022, and a reminder in November 2022, if no response was received. If unsuccessful, personal contacts were used where possible. The organisations themselves decided whom to register for participation. However, only one person per organisation could participate.

Preparation of the workshop

The researchers involved drafted recommendations based on the project results. To achieve this, they summarised the project results. In a brainstorming session, they discussed which recommendations for action can be derived from the results. Some recommendations for action were based on clear results, but in other cases the results contradicted each other. An assessment was made as to which recommendations were based on clear results within the project and whose implementation was considered practicable (feasible) and which were not (to be discussed). The recommendations were then made available to the project partners together with an accompanying explanatory text. The project partners were asked to take part in an online survey to vote on the extent to which the classification in the “feasible” category was appropriate. The recommendations were then re-categorised in line with the voting results, if necessary, and the comments were added anonymously as additional background information. The document, consisting of recommendations, accompanying explanatory text and possible comments from the project partners, was then made available to all workshop participants in advance.

Workshop

The workshop was conducted in April 2023. Information on the entire process related to the workshop can be found in Fig. 1.

Fig. 1
figure 1

Overall process

*category feasible is based on distinct project results and assessed as feasible by the project team; category to be discussed is based on contrary results and/or assessed to be difficult to implement

The Workshop was facilitated by JB (Introduction/Presentation of recommendations and rationale) and MN (neutral moderation/voting). It began with a short introduction of the project and its results to ensure a common knowledge of the topic. After this, the process of the World Café was introduced. Four tables on the topics (1) dissemination, (2) dissemination and use of the PVG in collaboration between healthcare providers and patients, (3) format/design and (digital) links, and (4) digitalisation/up-to-dateness were prepared in advance. Recommendations voted as “to be discussed” in advance were printed as a basis for discussion. Each table was hosted by a member of the project team (JH, NK, SW, JB) to ensure a focused discussion, because of the high number of recommendations assigned to each table. Furthermore, the host wrote down the discussion points on a flip chart and ensured that all group member were involved in the discussion. Participants were assigned to the groups in advance to ensure a heterogeneous composition. After 25 min, the groups switched to the next table. The host summarized the discussion points of the previous groups at the beginning. After the first two tables, there was a lunch break to promote personal exchange. Following the lunch break the discussion was continued until each group had discussed on every topic. After the hosts presented the results of the tables to the whole group, the voting was conducted. Participants voted in blocks on all recommendations from each topic that were a priori assigned to the “feasible” category. Recommendations assigned to the “to be discussed” category were voted individually. Participants could agree, disagree, or abstain from voting. Voting was open using coloured cards. Participants who abstained from voting were excluded from the total population for the calculation of the approval rate. Recommendations with agreement of > 75% were approved, in case of ≤ 75% agreement, recommendations were rejected. If organisations were unable to send a representative or its representative had to leave before voting was conducted for all recommendations, the right to vote could be transferred to the representative of another organisation.

Data synthesis

Following the workshop, the project team added the discussion points and the voting results to the recommendations developed in advance. The updated recommendations were uploaded to the project website and sent to all workshop participants as well as people who had expressed an interest in the project results.

Results

Participants

The five-hour workshop took place on 24th April 2023 in Cologne, Germany. 23 people from 24 organisations participated in the discussion. Four representatives from four organisations had to cancel their participation at short notice for various reasons.

Users of PVGs (patients (n = 6), medical staff (n = 4), and multipliers (n = 2)) were included as well as creators (n = 4) and initiators/funding organisations (n = 3) of PVGs and organisations with methodological expertise in the development of clinical practice guidelines (n = 2) or in patient health information (n = 3). In addition, one initiating organisation was not able to send a representative and therefore transferred its voting right for the whole workshop.

Recommendations on dissemination

In the topic area of dissemination, 13 recommendations were available for voting (three of which were in the “feasible” category). Two out of the 13 recommendations were rejected. The recommendations are shown in Table 1. The use of already existing structures for the dissemination of the PVGs was evaluated very positively. For example, they could be integrated into existing modules of training and continuing education curricula (on communication and evidence-based medicine for service providers (1.4). In addition, to use PVGs could be explicitly mentioned in the requirement catalogue of the oncological centres certified by the German Cancer Society; the current version of the catalogue only refers to patient information in general (1.5). The participants emphasized that this should not displace other high quality information materials. According to the participants, indexing the PVGs for search engine optimisation is very time-consuming because it is a complex technical process (1.6). The use of intuitive terminology on the cover page could already improve the search if necessary (2.4). The participants had a controversial discussion about the use of multilingual information materials such as flyers (1.7). In particular, the use of artificial intelligence was considered beneficial for translation into plain language. When providing information on the PVG in relevant scientific journals, it was assessed important to use free announcements and articles and no advertisement that has to be paid (1.8). Pointing out that congresses aimed at healthcare professionals are already adequately covered using fair stands for information, participants were in favour of presenting PVG at congresses for patients and patient representatives (1.9). The dissemination of the PVG via social media was rejected mainly for the perceived lack of resources (1.11). First, the establishment of structures for the collection of target group-specific media strategies was deemed necessary. The unsolicited sending of flyers and/or printed version of the PVG to relevant healthcare facilities was rejected with the argument that it would be a waste of resources (funds and material; 1.12). The future significance of digital health applications was discussed and partly doubted. Nevertheless, the reference to the PVG in existing digital health applications was evaluated positively (1.13).

Table 1 Recommendations on dissemination

Recommendations on design and format

In the topic area of design and format, seven recommendations were available for voting (2 of which were in the “feasible” category). Three out of the seven recommendations were rejected. The recommendations are shown in Table 2.

Participants pointed out that product neutrality is sometimes difficult to ensure, especially in the case of photos as distinct from images (2.3). Because the term PVG is not intuitively understandable, intuitive terminology is to be added to the term PVG on the cover page (2.4). Participants controversially discussed proposals for intuitive terminology and pointed out that it should be assessed in advance which terms are understandable for patients. Three recommendations were rejected in view of the high effort that would be involved (2.5–2.7).

Table 2 Recommendations on design and format

Recommendations on (digital) links

In the topic area of (digital) links, five recommendations were available for voting (2 of which were in the “feasible” category). None of the recommendations was rejected. The recommendations are shown in Table 3.

Participants emphasised that recurring cross-references to the explanations of the grading of recommendations are feasible in PDF brochures but not in printed brochures (3.2). They discussed various ways to optimise existing links to target websites (3.4) such as verification on update, annual verification or, in perspective, automated verification. It was assumed that the amount of resources required to create a digital one-pager that lists, among other things, updates to PVG content would be high (3.5). In addition, it was noted that an acceleration of editorial processes is needed to include new content in the one-pager in a timely manner.

Table 3 Recommendations on (digital) links

Recommendations on digitalisation

In the topic area of digitalisation, four recommendations were available for voting. One of the recommendations was rejected. The recommendations are shown in Table 4.

The participants appreciated the transfer of the content to an app (4.1). There are already plans for implementation. The transfer of the PVG into a digital health application was rejected due to the efforts associated with the benefit assessment in the development of a new digital health application (4.4). In Germany, digital health applications can be prescribed if proven beneficial. With regard to the integration into already existing digital health applications (1.13), the recommendation was rejected as redundant. Linking the PVG to the electronic patient record that is accessible for patients and medical personnel was appreciated (4.3). When linking the PVG to the electronic patient record, some participants emphasised the right of ignorance, so that consent to display the PVG should first be given first. Participants very much welcomed a voice output to make the PVG available to disadvantaged groups of people with physical disabilities (4.2). In case of foreign languages or plain language, a voice output in different languages is needed. According to the participants, this is already feasible for English, but the technology still needs further development for other languages.

Table 4 Recommendations on digitalisation

Recommendations on up-to-dateness

In the topic area of up-to-dateness, three recommendations were available for voting. One of the recommendations was rejected. The recommendations are shown in Table 5.

If the underlying CPG is a living CPG, there should be a transition of the PVG to a living PVG (5.1). This requires a simplification of the editorial structures in the development of PVGs. A corresponding simplification is also necessary if there is no living CPG, but the PVG updating process is still to be optimised (5.1.1). Overall, participants again advocated for a general acceleration/optimization of editorial structures in order to integrate new/relevant content into the PVGs more quickly. The display of notifications on the phone must be set individually by the user. Since the organisations that produce PVGs have no influence on this, the recommendation on push notifications (5.2) was rejected.

Table 5 Recommendations on up-to-dateness

Recommendations on use of the PVG in collaboration between healthcare providers and patients

In the topic area of use of the PVG in collaboration between healthcare providers and patients, three recommendations were available for voting (one of which was in the “feasible” category). All recommendations were approved. The recommendations are shown in Table 6.

The distribution of the PVG to patients was considered useful. First, PVG should be offered by physicians (6.2), and the multidisciplinary team should offer it in the subsequent healthcare process (6.3). On the one hand, participants emphasised the improvement of the physician-patient relationship through the implementation of active and/or passive handovers by the physicians as required (6.2); on the other hand, it was stressed that knowledge of the existence of the PVG is a prerequisite for this. Active handover refers to the delivery of the printed PVG, which is briefly introduced in a conversation. Passive handing over refers to the simple handing over of the PVG without any further reference. The latter can be used particularly when physicians feel that an active handover would be overwhelming at this point. However, a passive handover requires an active handover at a later stage. This is separate from the continuous reminder by other health professionals recommended in Recommendation 6.3.

Table 6 Recommendations on use of the PVG in collaboration between healthcare providers and patients

Discussion

All in all, 35 recommendations were part of the voting procedure. Of these, 28 recommendations were approved. The recommendations referred to the topics dissemination, design and format, (digital) links, digitalisation, up-to-dateness, and use of the PVG in collaboration between healthcare providers and patients. The recommendations address different stakeholders such as PVG creators, but also healthcare professionals.

Many recommendations refer to the dissemination of PVGs. This is particularly relevant in view of the insufficient awareness observed during the project. A number of participants (patients and healthcare providers) in the qualitative part of study indicated that they appreciated the concept of PVGs but had no awareness about it beforehand [22]. Considering that many participants perceived the PVG as a helpful tool for informed decision-making (data not yet published), the aim should be to increase awareness about the PVGs and their use. To this regard, we provide several recommendations with different approaches addressing patients or healthcare professionals. Different contexts such as training, certification and information policies addressing healthcare professionals are included. Furthermore, providing patient information in healthcare facilities, self-help groups and measures to increase the visibility of PVG in the context of the internet are addressed. A review found that many patients search the Internet for health information and that they most often use a search engine as a starting point [23]. Accordingly, it is important that PVGs can be found well when searching the internet via a search engine. However, many recommendations refer to the integration of PVG into already existing structures. Even though the recommendations provide a practical basis due to the involvement of divergent stakeholders, their implementation in practice is highly important. In this context, further research is needed. For example, a training session to teach physicians on how to integrate PVGs into the doctor-patient conversation could be developed. As a positive side effect, this would also increase doctors’ awareness of the PVGs. Possible obstacles to dealing with the PVGs during the doctor-patient-conversation in detail could be time restrictions experienced by the doctors or the patient-physician relationship. Furthermore, decreased cognitive capacities because of anxiety or stress can also play a role in the ability to perceive information [24]. The timing of the handover might play an important role in this context. According to a qualitative study oncological patients require relevant health information from a very early start [25]. The fact that this time is associated with a high level of emotion, particularly in the case of oncological diseases, can be a challenge in terms of handover. Appropriate training for service providers regarding the PVG could also provide assistance in this regard. After its implementation, such a training session could be integrated in the certification system of the German Cancer Society. This would lead to a higher awareness and use of the PVG on the physicians’ as well as the patients’ side.

The implementation of some recommendations would also enable people to use PVG who were previously unable or only partially able to do so due to various circumstances. In our recommendations, we refer to non-native speakers as well as people with impaired vision. There are further groups of people such as patients with intellectual disabilities [26] who may not be addressed by the PVGs. Because our project did not provide any results on this, they are not mentioned in the recommendations. Nevertheless, we want to emphasize the importance of addressing all target groups. This is certainly very challenging due to highly divergent needs. Information needs differ in terms of what information is needed, in what form and in what level of detail. A survey found that the Internet is the most frequently sought source of health information by both men and women [27]. However, the frequency of searching on the Internet also depends on underlying sociodemographic factors such as the socioeconomic status. In the course of a systematic review, it was found that information needs (of patients, relatives and the general population) vary in type and scope [28]. Beyond topics such as treatment, diagnosis, prevention and health promotion, aetiology, and prognosis, where information needs are high, information on topics such as rehabilitation and impact on social life was in demand less frequently. In this context, it would be helpful to individualise PVGs to a greater extent. The user test of a PVG also showed that some needs are so heterogeneous that individualisation, if possible, should be attempted [29]. If all potential information needs were addressed in a PVG, the scope would be far too large for many patients. This trade-off is a challenge that might be addressed by (digital) links or the use of different formats. The integration of PGVs in different formats such as apps or the electronic patient record could enable a staggered integration of the content.

At least at present, the implementation of a part of the recommendations is only possible for some of the formats offered. One example is the recurrent explanation of the grading of recommendations. This is easy to implement for PVGs in PDF format, but difficult in case of a printed PVG. However, printed PVGs continue to be very popular even though there might be differences between patient populations (e.g. age [22]).

Especially in the context of digitalisation, there are likely to be some opportunities for further development of PVGs in the future. Some of them are directly taken into account in our recommendations; others have been discussed in the context of the implementation of individual recommendations. This was the case, for example, with the recommendation to optimize existing links to target internet sites. Participants mentioned that this could be done automatically in the future.

Strength and limitations

Some limitations have to be considered when interpreting our results. Even though the list of participants is not exhaustive, the big players in the German field of PVGs and patient information took part. Due to time constraints, the recommendations from the “feasible” category could not be discussed in detail during the World Café. In the course of the voting procedure, there was restricted additional time for discussion, if necessary. Nevertheless, it became apparent that there was no need for discussion for most of the recommendations from the feasible category. However, for some of the other recommendations more discussion time would have been helpful. On the other hand, we assume that the time restriction could increase the participation rate by allowing the participants to arrive and depart on the day itself. The World Café was chosen to enable all stakeholder to participate in the discussion and to share their point of view. On the other hand, this left less time for discussion in the plenary session.

Additionally, some participants of the workshop gave the feedback, that they would have preferred an anonymous online voting procedure. Since there were also some delays in counting, especially when people changed their minds or needed longer time to think about it, the project team would use online voting procedure in the future.

In the course of the discussion, some participants expressed that they did not want to prescribe to specific addressees (e.g. German Cancer Aid) what they must do. The moderator then clarified that these were only recommendations and not obligations. Nevertheless, it cannot be ruled out that this misinterpretation may have influenced the voting behaviour of some participants.

Our project referred to oncological PVG only, therefore the majority of recommendations can only be applied to oncological PVG. This becomes clear, for example, in the recommendation 1.5 (integration of the PVG into the certification system of the German Cancer Society) or 1.10 (Prominent positioning of the PVG on the German Cancer Aid website) since they are specifically targeted at relevant stakeholders in the field of oncology. However, a number of the recommendations without named addressees also clearly belong to the field of oncological PVG. One example is recommendation 2.1 including the clearer presentation of the medical recommendation by using bold front. For oncological PVG, unlike other PVG, an italicized font has been used to date. However, this was described by some participants as not striking enough. Other recommendations may also apply to non-oncological PVG. Since the concept of PVGs was not well known, it can be assumed that this is a fundamental circumstance and not exclusively related to the field of oncology. Accordingly, it should be investigated to what extent measures to disseminate PVG, for example, can be implemented beyond oncology.

Considering all this, the project achieved practical recommendations under consideration of various perspectives. This can help to improve use and dissemination of (oncological) PVGs in Germany.

Conclusion

Overall, 35 recommendations were part of the voting procedure. Of these, 28 recommendations were approved. The recommendations referred to the topics dissemination, design and format, (digital) links, digitalisation, up-to-dateness, and use of the PVG in collaboration between healthcare providers and patients. The practical recommendations consider various perspectives and can help to improve use and dissemination of (oncological) PVGs in Germany.

Data availability

Most of the data generated or analysed during this study are included in this published article. Further details are available from the corresponding author on reasonable request.

Abbreviations

CPG:

Clinical Practice Guidelines

GGPO:

Office of the German Guideline Program in Oncology c/o German Cancer Society

PVG:

Patient version of clinical guideline

References

  1. Faller H, Koch U, Brähler E, Härter M, Keller M, Schulz H, et al. Satisfaction with information and unmet information needs in men and women with cancer. J Cancer Surviv. 2016;10(1):62–70.

    Article  PubMed  Google Scholar 

  2. Halbach SM, Enders A, Kowalski C, Pförtner T-K, Pfaff H, Wesselmann S, et al. Health literacy and fear of cancer progression in elderly women newly diagnosed with breast cancer–A longitudinal analysis. Patient Educ Couns. 2016;99 5:855–62.

    Article  Google Scholar 

  3. Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, et al. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns. 2012;89(2):345–52.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rood JAJ, Eeltink CM, van Zuuren FJ, Verdonck-de Leeuw IM, Huijgens PC. Perceived need for information of patients with haematological malignancies: a literature review. J Clin Nurs. 2015;24(3–4):353–69.

    Article  PubMed  Google Scholar 

  5. Husson O, Mols F, Van de Poll-Franse L. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2011;22(4):761–72.

    Article  CAS  PubMed  Google Scholar 

  6. Wang T, Molassiotis A, Chung BPM, Tan J-Y. Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review. BMC Palliat care. 2018;17(1):1–29.

    Article  Google Scholar 

  7. Yatim F, Cristofalo P, Minvielle E. What are the unmet information needs of cancer patients? A qualitative study. Global J Health Sci. 2017;9(12):114.

    Article  Google Scholar 

  8. Guidelines International Network (GIN). GIN Public Toolkit. Patient and public involvement in guidelines. 2021 https://g-i-n.net/wp-content/uploads/2022/01/Toolkit-combined.pdf

  9. Fervers B, Carretier J, Bataillard A. Clinical practice guidelines. J Visc Surg. 2010;147(6):e341–9.

    Article  CAS  PubMed  Google Scholar 

  10. Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, van der Wees P. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156(7):525–31.

    Article  PubMed  Google Scholar 

  11. Institute of Medicine. Clinical practice guidelines we can trust. Washington, DC, USA: National Academies; 2011.

    Google Scholar 

  12. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice. G. Clinical Practice Guidelines: Directions for a New Program. Field MJ, Lohr KN, editors. Washington (DC), USA: The National Academies Press; 1990.

  13. Santesso N, Morgano GP, Jack SM, Haynes RB, Hill S, Treweek S, et al. Dissemination of clinical practice guidelines: a content analysis of patient versions. Med Decis Mak. 2016;36(6):692–702.

    Article  Google Scholar 

  14. Fearns N, Kelly J, Callaghan M, Graham K, Loudon K, Harbour R et al. What do patients and the public know about clinical practice guidelines and what do they want from them? A qualitative study. BMC Health Serv Res. 2016;16(1).

  15. Liira H, Saarelma O, Callaghan M, Harbour R, Jousimaa J, Kunnamo I, et al. Patients, health information, and guidelines: a focus-group study. Scand J Prim Health Care. 2015;33(3):212–9.

    Article  PubMed  PubMed Central  Google Scholar 

  16. German Cancer Aid. Ordering information material. 2023 https://www.krebshilfe.de/informieren/ueber-krebs/infothek/infomaterial-kategorie/patientenleitlinien/

  17. German Guideline Program in Oncology (GGPO). Patient versions of clinical guidelines. 2023 https://www.leitlinienprogramm-onkologie.de/patientenleitlinien/

  18. Ärztliches Zentrum für Qualität in der Medizin (ÄZQ). Office des Leitlinienprogramms Onkologie (OL), AWMF-Institut für Medizinisches Wissensmanagement (AWMF-IMWi). Erstellung von Patientenleitlinien zu S3-Leitlinien/NVL im Rahmen der Leitlinienprogramme. Methodenreport. 2. Auflage, Version 1. https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Methodik/Erstellung-PLL-NVL-OL-MR_2Aufl.pdf2019.

  19. Meyer N, Hellbrecht I, Breuing J, Hauprich J, Wahlen S, Könsgen N, et al. Heterogeneous methodology in the development of patient versions of clinical practice guidelines-a scoping review. J Clin Epidemiol. 2023;161:53–64.

    Article  PubMed  Google Scholar 

  20. Becker M, Buhn S, Meyer N, Blodt S, Carl G, Follmann M, et al. Investigating the role and applicability of patient versions of guidelines in oncology and deriving recommendations for the development, dissemination and implementation of patient versions in Germany: protocol for multiphase study. BMJ Open. 2022;12(3):e059040.

    Article  PubMed  PubMed Central  Google Scholar 

  21. The World Café Community Foundation. The World Café™ 2018 http://www.theworldcafe.com

  22. Wahlen S, Breuing J, Becker M et al. Use, applicability, and dissemination of patient versions of clinical practice guidelines in oncology in Germany: a qualitative interview study with healthcare providers. BMC Health Serv Res. 2024;24(1): 272

  23. Zschorlich B, Gechter D, Janßen IM, Swinehart T, Wiegard B, Koch K. Health information on the internet: who is searching for what, when and how? Zeitschrift fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen. 2015;109(2):144–52.

  24. Brashers DE, Goldsmith DJ, Hsieh E. Information seeking and avoiding in Health contexts. Hum Commun Res. 2002;28(2):258–71.

    Article  Google Scholar 

  25. Krieger T, Salm S, Dresen A, Cecon N. Cancer patients’ experiences and preferences when receiving bad news: a qualitative study. J Cancer Res Clin Oncol. 2023;149(7):3859–70.

    Article  PubMed  Google Scholar 

  26. Newman B. Using easy read information about mental health for people with intellectual disability. UNSW Sydney; 2020.

  27. Horch K. Searching for health information on the internet-results from the KomPaS study. J Health Monit. 2021;6(2):67.

    PubMed  PubMed Central  Google Scholar 

  28. Pieper D, Jülich F, Antoine S-L, Bächle C, Chernyak N, Genz J, et al. Studies analysing the need for health-related information in Germany-a systematic review. BMC Health Serv Res. 2015;15(1):1–18.

    Article  Google Scholar 

  29. Fearns N, Graham K, Johnston G. Improving the user experience of patient versions of clinical guidelines: user testing of a Scottish Intercollegiate Guideline Network (SIGN) patient version. BMC Health Serv Res. 2015;16(1):1–10.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all participants of the project for their time and participation.

Funding

The AnImPaLLO project was supported by the Innovation Committee of the Federal Joint Committee (Innovation Fund, grant number: 01VSF20022).

Open Access funding enabled and organized by Projekt DEAL.

Author information

Authors and Affiliations

Authors

Contributions

JB, JH, SW, NK conceived and designed the workshop. JH, SW, JB, NK developed the recommendations. The other authors (IH, MB, SBü, NM, SBl, GC, MF, SF, TL, MN, CS, DP) reviewed and approved the final recommendations. NK, IH recruited the participants. NK, JH, SW, JB, MN conducted the World Café and NK, JH, SW, JB analysed the data. NK, SW, JB drafted the manuscript. All authors reviewed drafts of the manuscript and approved the final manuscript.

Corresponding author

Correspondence to Nadja Könsgen.

Ethics declarations

Ethics approval and consent to participate

This study was part of the AnImPaLLO project that was approved by the University Witten/Herdecke Ethics Committee (160/2021). All procedures were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all the participants.

Consent for publication

Not applicable.

Competing interests

MB was involved in the development of patient versions of clinical practice guidelines (PVGs) of oncology in Germany. SBl and MN are representatives of the AWMF, which receives constant financial support from the GGPO and is involved in methodological counselling for clinical practice guidelines (CPGs) in oncology and other CPGs. MF is a representative publisher of PVGs in oncology in Germany and is involved in the methodological counselling of CPGs and PVGs in oncology. TL is a representative publisher of PVGs of oncology in Germany. CS was involved in the development of PVGs in oncology in Germany until 2019 and is responsible for the development of PVGs of the National Program for Disease Management Guidelines (NDMG) and their methodological refinement. All other authors declare no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Könsgen, N., Hauprich, J., Wahlen, S. et al. Recommendations to improve use and dissemination of patient versions of oncological clinical practice guidelines in Germany: results of a multi-stakeholder workshop. BMC Public Health 24, 2393 (2024). https://doi.org/10.1186/s12889-024-19893-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-19893-w

Keywords